» Articles » PMID: 10542019

Amino Acid Substitutions at Position 481 Differently Affect the Ability of the Measles Virus Hemagglutinin to Induce Cell Fusion in Monkey and Marmoset Cells Co-expressing the Fusion Protein

Overview
Journal Arch Virol
Specialty Microbiology
Date 1999 Oct 29
PMID 10542019
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The hemagglutinin (H) protein of the measles virus (MV) Edmonston strain induced cell fusion in Cos (monkey) and B95a (marmoset) cells, when co-expressed with the fusion (F) protein, whereas the H protein of the wild-type KA strain induced fusion in B95a cells, but not in Cos cells. Asparagine residue at position 481 of the KA H protein was replaced by various amino acids through site-directed mutagenesis. Substitution with tyrosine, which was found at position 481 of the Edmonston H protein, enabled the mutant KA H protein (N481Y) to induce cell fusion in Cos cells co-expressing the F protein, which could be completely blocked by anti-CD46 antibody. This mutant, however, did not cause CD46 downregulation, unlike the Edmonston H protein. The other H protein mutants (N481S, N481T, N481D, N481H, N481F) did not produce syncytia in Cos cells. On the other hand, all of the mutants retained the ability to induce cell fusion in B95a cells. Thus, while tyrosine at position 481 was indispensable for the MV H protein's interaction with CD46, the residue at this position does not appear to be critically involved in the interaction with the receptor for wild-type strains present on B95a cells.

Citing Articles

Advances in the design and development of oncolytic measles viruses.

Hutzen B, Raffel C, Studebaker A Oncolytic Virother. 2016; 4:109-18.

PMID: 27512675 PMC: 4918395. DOI: 10.2147/OV.S66078.


Previously unrecognized amino acid substitutions in the hemagglutinin and fusion proteins of measles virus modulate cell-cell fusion, hemadsorption, virus growth, and penetration rate.

Okada H, Itoh M, Nagata K, Takeuchi K J Virol. 2009; 83(17):8713-21.

PMID: 19553316 PMC: 2738167. DOI: 10.1128/JVI.00741-09.


Measles virus for cancer therapy.

Russell S, Peng K Curr Top Microbiol Immunol. 2009; 330:213-41.

PMID: 19203112 PMC: 3926122. DOI: 10.1007/978-3-540-70617-5_11.


Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin.

Tahara M, Takeda M, Shirogane Y, Hashiguchi T, Ohno S, Yanagi Y J Virol. 2008; 82(9):4630-7.

PMID: 18287234 PMC: 2293038. DOI: 10.1128/JVI.02691-07.


A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism.

Takeda M, Tahara M, Hashiguchi T, Sato T, Jinnouchi F, Ueki S J Virol. 2007; 81(21):12091-6.

PMID: 17715217 PMC: 2168767. DOI: 10.1128/JVI.01264-07.